miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer - PubMed (original) (raw)
miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer
Hua Sui et al. Mol Cancer Ther. 2014 Dec.
Abstract
MicroRNA-200c (miR200c) recently emerged as an important regulator of tumorigenicity and cancer metastasis; however, its role in regulating multidrug resistance (MDR) remains unknown. In the current study, we found that the expression levels of miR200c in recurrent and metastatic colorectal cancers were significantly lower, whereas the JNK2 expression was higher compared with primary tumors. We showed that in MDR colorectal cancer cells, miR200c targeted the 3' untranslated region of the JNK2 gene. Overexpression of miR200c attenuated the levels of p-JNK, p-c-Jun, P-gp, and MMP-2/-9, the downstream factors of the JNK signaling pathway, resulting in increased sensitivity to chemotherapeutic drugs, which was accompanied by heightened apoptosis and decreased cell invasion and migration. Moreover, in an orthotopic MDR colorectal cancer mouse model, we demonstrated that overexpression of miR200c effectively inhibited the tumor growth and metastasis. At last, in the tumor samples from patients with locally advanced colorectal cancer with routine postsurgical chemotherapy, we observed an inverse correlation between the levels of mRNA expression of miR200c and JNK2, ABCB1, and MMP-9, thus predicting patient therapeutic outcomes. In summary, we found that miR200c negatively regulated the expression of JNK2 gene and increased the sensitivity of MDR colorectal cancer cells to chemotherapeutic drugs, via inhibiting the JNK2/p-JNK/p-c-Jun/ABCB1 signaling. Restoration of miR200c expression in MDR colorectal cancer may serve as a promising therapeutic approach in MDR-induced metastasis.
©2014 American Association for Cancer Research.
Similar articles
- Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells.
Xia Y, Yang W, Bu W, Ji H, Zhao X, Zheng Y, Lin X, Li Y, Lu Z. Xia Y, et al. J Biol Chem. 2013 Jul 5;288(27):19321-9. doi: 10.1074/jbc.M113.475442. Epub 2013 May 15. J Biol Chem. 2013. PMID: 23678002 Free PMC article. - Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao SD, Ran ZH. Zhu MM, et al. PLoS One. 2012;7(8):e41763. doi: 10.1371/journal.pone.0041763. Epub 2012 Aug 1. PLoS One. 2012. PMID: 22870247 Free PMC article. - COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.
Sui H, Zhou S, Wang Y, Liu X, Zhou L, Yin P, Fan Z, Li Q. Sui H, et al. Carcinogenesis. 2011 May;32(5):667-75. doi: 10.1093/carcin/bgr016. Epub 2011 Feb 3. Carcinogenesis. 2011. PMID: 21296766 - JNK2: a negative regulator of cellular proliferation.
Sabapathy K, Wagner EF. Sabapathy K, et al. Cell Cycle. 2004 Dec;3(12):1520-3. doi: 10.4161/cc.3.12.1315. Epub 2004 Dec 18. Cell Cycle. 2004. PMID: 15611655 Review.
Cited by
- YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.
Sui H, Zhang L, Gu K, Chai N, Ji Q, Zhou L, Wang Y, Ren J, Yang L, Zhang B, Hu J, Li Q. Sui H, et al. Cell Commun Signal. 2020 Jul 16;18(1):113. doi: 10.1186/s12964-020-00596-9. Cell Commun Signal. 2020. PMID: 32677955 Free PMC article. - MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.
Wang SJ, Cao YF, Yang ZQ, Jiang ZY, Cai B, Guo J, Zhang S, Zhang XL, Gao F. Wang SJ, et al. Oncol Lett. 2017 Feb;13(2):722-730. doi: 10.3892/ol.2016.5463. Epub 2016 Dec 6. Oncol Lett. 2017. PMID: 28356951 Free PMC article. - The Different Mechanisms of Cancer Drug Resistance: A Brief Review.
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. Mansoori B, et al. Adv Pharm Bull. 2017 Sep;7(3):339-348. doi: 10.15171/apb.2017.041. Epub 2017 Sep 25. Adv Pharm Bull. 2017. PMID: 29071215 Free PMC article. Review. - MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
Zhao L, Wang Y, Jiang L, He M, Bai X, Yu L, Wei M. Zhao L, et al. J Exp Clin Cancer Res. 2016 Feb 3;35:25. doi: 10.1186/s13046-016-0300-8. J Exp Clin Cancer Res. 2016. PMID: 26842910 Free PMC article. - Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies.
Madurantakam Royam M, Kumarasamy C, Baxi S, Gupta A, Ramesh N, Kodiveri Muthukaliannan G, Jayaraj R. Madurantakam Royam M, et al. Mol Diagn Ther. 2019 Feb;23(1):65-82. doi: 10.1007/s40291-019-00381-6. Mol Diagn Ther. 2019. PMID: 30726546
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous